Global Stock News

Assessing Zoetis After Recent FDA Approval and Share Price Slide in 2025

Assessing Zoetis After Recent FDA Approval and Share Price Slide in 2025

Thinking about Zoetis and whether to hang on, buy more, or move on? You are far from alone; the stock has made some surprising moves lately and investors everywhere are asking the same questions. After a modest 0.5% gain over the past week, Zoetis is still sitting well below its recent peaks, down 3.2% over the last month and trailing by a hefty 24.5% versus this time last year. It’s clear the risk perception around Zoetis has changed, perhaps spurred on by shifting sentiment in the broader animal health market and a cautious approach from institutional investors.

Of course, numbers like a -1.6% return over three years and -6.4% over five years tell their own story, but they don’t always say what is coming next. With the latest close at…

Source link

Share this article

Scroll to Top